Skip to main content
SpringerLink
Log in
Book cover

Good Pharma pp 91–116Cite as

Palgrave Macmillan

Educating the Public and Future Researchers

  • Chapter

  • 139 Accesses

Abstract

From the earliest years, as we mentioned in Chapter 2, one of the main goals of the original group of young, talented researchers as they founded the Mario Negri Institute for Pharmacological Research was to share their model of research integrity with the public, as well as with doctors and their patients. The Institute’s three pillars were research, training, and communication. Their sense of research with a social mission led them to breakout practices like speaking against unhealthy dependencies on dangerous drugs like cigarettes, or treatments without evidence, or pseudoscientific fads by doctors like useless cures for cancer. Mario Negri leaders became public intellectuals who also weighed in on a number of other issues.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. Maturo A. Sociologia della Malattia. Milano: FrancoAngeli; 2007.

    Google Scholar 

  2. Shim J. Cultural health capital. A theoretical approach to understanding health care interactions and the dynamics of unequal treatments. Journal of Health and Social Behavior. 2010; 51 (1): 1–15.

    Article  Google Scholar 

  3. Cipolla C. Perché non possiamo non essere eclettici. Il sapere sociale nella web society Milano: FrancoAngeli; 2012.

    Google Scholar 

  4. Mosconi P, Colombo C. Fostering a strategic alliance between patients’ associations and health care professionals. Journal of Ambulatory Care Management. 2010; 33 (3): 223–230.

    Article  Google Scholar 

  5. Mosconi P, Colombo C, Villani W, Liberati A, Satolli R. PartecipaSalute: a research project and a training program tailored on consumers and patients. In: Albolino S, ed. Healthcare Systems Ergonomics and Patient Safety. London: Taylor & Francis; 2011: 71–76.

    Google Scholar 

  6. Mosconi P, Colombo C, Satolli R, Liberati A. PartecipaSalute, an Italian project to involve lay people, patients’ associations and scientific-medical representatives in the health debate. Health Expectations. 2006; 10: 194–204.

    Article  Google Scholar 

  7. Fadden R, Powers M. A social justice framework for health and social policy. Cambridge Quarterly of Healthcare Ethics. 2011; 20: 596–604.

    Article  Google Scholar 

  8. Richards T, Montori V, Godlee F, Lapsley P, Paul D. Let the patient revolution begin. BMJ 2013; 346: f2614.

    Google Scholar 

  9. Maturo A. Network governance as a response to risk society’s dilemmas: a proposal from sociology of health. Topoì—International Review of Philosophy. 2004; 23 (II): 195–202.

    Google Scholar 

  10. Segall S. Is health care (still) special? Journal of Political Philosophy. 2007; 4 (2): 242–263.

    Google Scholar 

  11. Bloom SW. The Doctor and His Patient. New York: Russell Sage Foundation; 1963.

    Google Scholar 

  12. Maturo A. The medicalization of education: ADHD, human enhancement, and academic performance. Italian Journal of Sociology of Education. 2013; 5 (3): 178–188.

    Google Scholar 

  13. Maturo A. The shifting borders of medicalization: perspective and dilemmas of human enhancement. In: Maturo A, Conrad P, eds. The Medicalization of Life, Salute e Società. Vol. VIII. Bologna 2009: 13–30.

    Google Scholar 

  14. Bonati M. Reducing overdiagnosis and disease mongering in ADHD in Lombardy. BMJ. 2013; 347: f7474.

    Google Scholar 

  15. Affaritaliani. Garattini contro omeopatia e agopuntura negli ospedali: “A quando maghi e fattucchieri?” Affar Italiani: Affaritaliani.It; 2011 (Apr 26).

    Google Scholar 

  16. Invernizzi G. Fumo di tabacco e salute respiratoria nella donna: il ruolo del medico di famiglia. Milano: Rivista della Società Italiana di Medicina Generale; 2010

    Google Scholar 

  17. Gallus S, Murisic B, La Vecchia C. Anti-smoking campaigns in Italy: the role of the Mario Negri Institute for Pharmacological Research. Milano: Mario Negri Institute for Pharmacological Research; 2013.

    Google Scholar 

  18. La Vecchia C, Garattini S. Italy—attitudes to legislation on restriction of smoking. The Lancet. 1987; 329 (8545): 1310.

    Article  Google Scholar 

  19. Gallus S, Zuccaro P, Colombo P, et al. Effects of new smoking regulations in Italy. Annals of Oncology. 2006; 17: 346–347.

    Article  Google Scholar 

  20. Bocci M. Intervista a Silvio Garattini, “Una terapia non si approva per sentenza”. la Repubblica. 2012 (Sept 1): 17.

    Google Scholar 

  21. Gualtani A, De Francesco L, Garattini S. Reduced use of laboratory animals in research institute. The Lancet. 1997; 349 (9064): 1557–58.

    Article  Google Scholar 

  22. Garattini S. Forward: The necessity of animal experimentation. In: Garattini S, van Bekkum D, eds. The Importance of Animal Experimentation for Safety and Biomedical Research. Dordrecht: Kluwer Academic Publishers; 1990: vii–3.

    Chapter  Google Scholar 

  23. Editors. Italian biomedical research under fire. Nature Neuroscience. 2013 (Nov 22); 16 (1709): doi: 10.1030/nn.3595.

    Article  Google Scholar 

  24. Tulli dF. Garattini, S. “Non chiamatela vivisezione.” Left. Rome 2013 (30 Nov).

    Google Scholar 

  25. Rosati E. “Umberto Veronesi e Silvio Garattini, due scienziati a confronto.” OGGI. 2012 (March).

    Google Scholar 

  26. Sztompka P. Trust: A Sociological Theory. Cambridge, UK: Cambridge University Press; 1999.

    Google Scholar 

  27. Leonardi A. Interview with Alfredo Leonardi, Ricercatori formati sul campo di battaglia. Negri News. Vol XIII. Milano: Mario Negri Institute for Pharmacological Research; 1981.

    Google Scholar 

  28. Schein EH. Organizational Culture and Leadership. 3rd ed. San Francisco: JosseyBass; 2004.

    Google Scholar 

  29. Kelley R, Caplan J. How Bell Labs creates star performers. Harvard Business Review. Jul-Aug 1993; 71 (4): 128–139.

    Google Scholar 

  30. Jori A. Quarantaquattro anni dopo. MarioNegri News. 2005: 3–5.

    Google Scholar 

  31. Bendotti C. “Studio come vincere la SLA. Intanto ho vinto il mio tumore” (I study how to beat SLA and meantime defeated my cancer.). L’Eco di Bergamo. 2011 (Oct 11).

    Google Scholar 

  32. Cowan A, Ghezzi D, Samanin R. Effect of midbrain raphe lesion and 6-hydroxydopamine on the antinociceptive action of buprenorphine in rats. Archives Internationales de Pharmacodynamie et de Therapie 1974; 208: 302–305.

    Google Scholar 

  33. Adler MW, Manara L, Samanin R, eds. Factors Affecting the Action of Narcotics. New York: Raven 1978. In Garattini S, ed. The Mario Negri Monograph Series.

    Google Scholar 

Download references

Authors
  1. Donald W. Light
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio F. Maturo
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2015 Donald W. Light and Antonio F. Maturo

About this chapter

Cite this chapter

Light, D.W., Maturo, A.F. (2015). Educating the Public and Future Researchers. In: Good Pharma. Palgrave Macmillan, New York. https://doi.org/10.1057/9781137374332_5

Download citation

Publish with us

Policies and ethics

Search

Navigation